Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

The University of Hong Kong167 enrolled

Overview

Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.

1. Primary outcome: Incidence of cardiometabolic diseases in subjects with OSA over 9 years. 2. Secondary outcomes: Effects of CPAP treatment on cardiometabolic conditions

Study Type

OBSERVATIONAL

Enrollment

167

Conditions

Obstructive Sleep Apnea Cardiovascular Diseases Metabolic Diseases

Eligibility

Sex: MALEMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * From previous cohort for reassessment. Exclusion Criteria: * Unstable medical conditions

Locations (1)

Queen Mary Hospital

Hong Kong, Hong Kong

RECRUITING

Outcomes

Primary Outcomes

Incidence of cardiometabolic complications

167 subjects recruited from our previous "OSA and metabolic syndrome" (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.

Time frame: 9 years

Secondary Outcomes

Effects of CPAP treatment on cardiometabolic conditions

Time frame: 9 years

Central Contacts

Jamie C Lam, MD

CONTACT

852-22555906 lamcmj@hku.hk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.